BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17640107)

  • 1. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.
    Skrepnek GH
    Pharmacoeconomics; 2007; 25(8):649-64. PubMed ID: 17640107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian analysis: a new statistical paradigm for new technology.
    Grunkemeier GL; Payne N
    Ann Thorac Surg; 2002 Dec; 74(6):1901-8. PubMed ID: 12643371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian approach to stochastic cost-effectiveness analysis.
    Briggs AH
    Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
    Stevens JW; O'Hagan A
    Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.
    Cloutier LM; Sirois S
    Drug Discov Today; 2008 Jun; 13(11-12):536-42. PubMed ID: 18549981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bayesian approach for the cost-effectiveness evaluation of healthcare technologies].
    Berchialla P; Gregori D; Brunello F; Veltri A; Petrinco M; Pagano E
    Epidemiol Prev; 2009; 33(3):123-8. PubMed ID: 19776461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joining forces of Bayesian and frequentist methodology: a study for inference in the presence of non-identifiability.
    Raue A; Kreutz C; Theis FJ; Timmer J
    Philos Trans A Math Phys Eng Sci; 2013 Feb; 371(1984):20110544. PubMed ID: 23277602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Null Hypotheses, Interval Estimation, and Bayesian Analysis.
    Shin JJ; Zurakowski D
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):919-920. PubMed ID: 29192854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical weighted Bayesian tolerance intervals.
    Tran H
    J Biopharm Stat; 2021 Mar; 31(2):180-190. PubMed ID: 32997587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayeswatch: an overview of Bayesian statistics.
    Austin PC; Brunner LJ; Hux JE
    J Eval Clin Pract; 2002 May; 8(2):277-86. PubMed ID: 12060417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bayesian inference in clinical reasoning].
    Canals L M
    Rev Med Chil; 2019 Feb; 147(2):231-237. PubMed ID: 31095172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of parameter uncertainty for an activated sludge model using Bayesian inference: a comparison with the frequentist method.
    Zonta ZJ; Flotats X; Magrí A
    Environ Technol; 2014 Aug; 35(13-16):1618-29. PubMed ID: 24956752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian demography 250 years after Bayes.
    Bijak J; Bryant J
    Popul Stud (Camb); 2016; 70(1):1-19. PubMed ID: 26902889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting the results of clinical trials, embracing uncertainty: A Bayesian approach.
    Frost SA; Alexandrou E; Schulz L; Aneman A
    Acta Anaesthesiol Scand; 2021 Feb; 65(2):146-150. PubMed ID: 33051864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian methods in health technology assessment: a review.
    Spiegelhalter DJ; Myles JP; Jones DR; Abrams KR
    Health Technol Assess; 2000; 4(38):1-130. PubMed ID: 11134920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of Bayesian reasoning in the analysis of delay-discounting data.
    Franck CT; Koffarnus MN; McKerchar TL; Bickel WK
    J Exp Anal Behav; 2019 Mar; 111(2):239-251. PubMed ID: 30779349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.